Fee Strctures for Pharmaceutical Biotechnology Research Projects:

Fee Reduction Chances:

1. Group Reductions: Given for all durations for students who are joining in a group of 4 and above. There will be a considerable reduction given on total fee per head. Contact on below given number.
2. Early Bird Reductions: Given for all students who are registering minimum three months before joining date. There will be 20% reduction given on total fee. Contact on below given number.
3. MoU Reductions: Given for all students who are joining from institutions which has MoU with NTHRYS BIOTECH LABS will. There will be considerable reduction given on total fee. Contact on below given number.
4. Toppers Reduction: Given for 3 months and above durations for all students who are top rankers in their institutions. Students can request fee reduction with the help of the head of institution (Principal, Not HOD) from the principals official email id. Contact on below given number.
5. Economically Backward Class Reductions: Given for all durations to all students belonging to economically backward class can request for fee reduction. Contact on below given number.

Important Note: Candidates may apply only one type of reduction from the aforementioned list at any given time.

Application Process

1. Reg Fee payment screenshot / photocopy (Paid via "Pay Reg Fee" button available on "Fee" tab
2. Any ID Card Photocopy
3. Draft an email with 1, 2 as attachments, provide Postal Address along with parents name and pincode, and email id, mobile number and joining date.
4. Send the above drafted mail to counselor.bio ( a t ) nthrys.com
5. Update about the email as well as send payment screenshot / photocopy via whatsapp on +91-7993084748
6. Our Academic Services department will confirm the application with in 10 mins to 1 hour.

Testimonials

Frequently Asked Questions (FAQs)

Placement Assistance

NTHRYS Updates

1. Commence of NTHRYS Abstract and Indexing Services

   NTHRYS Biotech Labs is commencing its Abstract and Indexing Services linking to its own in house build Research Objectives ID (RO) database.. There is a gap for a perfect global research abstract and indexing database which can organise research works based -on their objectives rather than just author given keywords. This is exactly the approach NTHRYS BIOTECH LABS want to execute and bring to reality in its upcoming NTHRYS Research Objectives based Abstract and Indexing (NRO-AI). Systemic Intelligence algorithms are designed to serve the users for this NRO-AI engine.

2. Biopesticides CRY Proteins database completion

   Bacillus thuringiensis produces CRY proteins that are specific to insect gut cell linings. Bt CRY Proteins to their respective Insect Cell Lines specificity database is completed by NTHRYS Team. Its completion has simplified Crop specific biopesticide strains allocation strategy design.

3. Plant Probiotics

   Introducing our Revolutionary Plant Probiotics: Cultivating Greener Futures. Discover our latest endeavor in sustainable agriculture – the launch of our groundbreaking Plant Probiotics product line. Uncover the secrets to healthier, more vibrant plants as we delve into the world of beneficial microorganisms and their transformative effects -on cultivation practices. Stay tuned for updates and insights that will redefine your approach to plant care and contribute to a greener, more sustainable future. Open

4. MDR Research Commencement

   Multi Drug Resistance (MDR) research employs cutting-edge methodologies, like genomics and high-throughput screening, to decipher how drug-resistant pathogens evolve, aiming to uncover new treatment targets and transform global health defenses against these resilient threats. In the realm of combating Multi Drug Resistance (MDR), our research endeavors have evolved to embrace sophisticated methodologies at the frontier of medical innovation. Through an intricate fusion of genomics, proteomics, and high-throughput screening techniques, our approach confronts the formidable challenge posed by drug-resistant pathogens. Employing state-of-the-art molecular assays and computational analyses, our methodologies aim to decipher the underlying mechanisms driving resistance evolution. This pioneering strategy -not -only dissects the intricate pathways of resistance but also seeks to unveil -novel therapeutic targets. By amalgamating diverse scientific disciplines and leveraging the latest technological advancements, our efforts strive to revolutionize the fight against MDR, forging a pathway to safeguard global health.